Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

21st February 2020 Uncategorised 0

For the second time this month, Gilead has suffered a setback in its public patent dispute with the U.S. government. A patient review board decided against striking up a review of HHS patents on HIV prevention drug Truvada after Gilead argued they were invalid.

More: Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
Source: fierce